Prot #TA799-007: A Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Apraglutide in Adult Subjects with Short Bowel Syndrome and Intestinal Failure (SBS-IF)

Project: Research project

Project Details

StatusActive
Effective start/end date10/24/22 → 10/24/25

Funding

  • PSI Pharma Support America Inc. ((OE) Prot #TA799-007 // (OE) Prot #TA799-007)
  • VectivBio AG ((OE) Prot #TA799-007 // (OE) Prot #TA799-007)